ARS Pharmaceuticals to Participate in the SVB Securities
SAN DIEGO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company
Globe Newswire9-02-2023, 18:32
Etherealize Raises $40 Million to Rewire Wall Street’s Infrastructure with Ethereum 3-09-2025, 20:00